XML 15 R8.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jul. 12, 2025
Jul. 13, 2024
Cash flows from operating activities    
Net earnings $ 8,270 $ 24,460
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Non-cash restructuring, asset impairment, and other charges (835) 12,129
Depreciation and amortization 64,719 53,988
Non-cash rent (4,367) (1,676)
LIFO expense 8,106 3,529
Postretirement benefits expense (income) 213 (1,085)
Deferred income taxes 12,483 4,254
Stock-based compensation expense 8,770 5,576
Stock warrant 298 516
Loss on disposals of assets 237 44
Other operating activities 1,003 991
Changes in operating assets and liabilities:    
Accounts receivable (1,913) (3,619)
Inventories 7,308 48,517
Prepaid expenses and other assets 10,042 2,213
Accounts payable 36,636 9,962
Accrued payroll and benefits (25,090) (25,604)
Current income taxes (11,418) (3,604)
Other accrued expenses and other liabilities (1,899) 1,507
Net cash provided by operating activities 112,563 132,098
Cash flows from investing activities    
Purchases of property and equipment (51,179) (67,074)
Net proceeds from the sale of assets 137 1,901
Acquisitions, net of cash acquired 0 (14,898)
Loans to customers (7,707) 0
Payments from customers on loans 2,772 983
Other investing activities (3,468) (407)
Net cash used in investing activities (59,445) (79,495)
Cash flows from financing activities    
Proceeds from senior secured credit facility 787,690 715,399
Payments on senior secured credit facility (810,947) (721,069)
Repayment of other long-term debt and finance lease liabilities (7,015) (5,879)
Share repurchases 0 (15,051)
Net payments related to stock-based award activities (2,722) (3,181)
Dividends paid (15,476) (15,360)
Other financing activities (714) (184)
Net cash used in financing activities (49,184) (45,325)
Net increase in cash and cash equivalents 3,934 7,278
Cash and cash equivalents at beginning of period 21,570 17,964
Cash and cash equivalents at end of period $ 25,504 $ 25,242